NTRA Natera Inc

Price (delayed)

$36.86

Market cap

$3.55B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.89

Enterprise value

$3.79B

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a ...

Highlights
NTRA's revenue is up by 49% year-on-year and by 7% since the previous quarter
Natera's gross profit has increased by 40% YoY
NTRA's equity is up by 46% year-on-year but it is down by 17% since the previous quarter
Natera's net income has plunged by 112% YoY and by 16% from the previous quarter
The EPS has plunged by 89% YoY and by 13% from the previous quarter

Key stats

What are the main financial stats of NTRA
Market
Shares outstanding
96.31M
Market cap
$3.55B
Enterprise value
$3.79B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.49
Price to sales (P/S)
5.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.68
Earnings
Revenue
$667.3M
EBIT
-$537.48M
EBITDA
-$514.07M
Free cash flow
-$444.29M
Per share
EPS
-$5.89
Free cash flow per share
-$4.65
Book value per share
$5.68
Revenue per share
$6.98
TBVPS
$11.98
Balance sheet
Total assets
$1.14B
Total liabilities
$602.33M
Debt
$398.24M
Equity
$542.34M
Working capital
$749.15M
Liquidity
Debt to equity
0.73
Current ratio
4.24
Quick ratio
3.98
Net debt/EBITDA
-0.47
Margins
EBITDA margin
-77%
Gross margin
46.8%
Net margin
-81.9%
Operating margin
-81.3%
Efficiency
Return on assets
-48.1%
Return on equity
-97%
Return on invested capital
-44.4%
Return on capital employed
-58.8%
Return on sales
-80.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NTRA stock price

How has the Natera stock price performed over time
Intraday
-2.28%
1 week
3.83%
1 month
-10.51%
1 year
-68.33%
YTD
-60.53%
QTD
-9.39%

Financial performance

How have Natera's revenue and profit performed over time
Revenue
$667.3M
Gross profit
$312.48M
Operating income
-$542.29M
Net income
-$546.46M
Gross margin
46.8%
Net margin
-81.9%
Natera's operating income has shrunk by 122% YoY and by 16% QoQ
Natera's net income has plunged by 112% YoY and by 16% from the previous quarter
NTRA's revenue is up by 49% year-on-year and by 7% since the previous quarter
NTRA's operating margin is down by 49% year-on-year and by 9% since the previous quarter

Growth

What is Natera's growth rate over time

Valuation

What is Natera stock price valuation
P/E
N/A
P/B
6.49
P/S
5.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.68
The EPS has plunged by 89% YoY and by 13% from the previous quarter
The stock's P/B is 79% less than its 5-year quarterly average of 31.3 and 61% less than its last 4 quarters average of 17.0
NTRA's equity is up by 46% year-on-year but it is down by 17% since the previous quarter
NTRA's price to sales (P/S) is 63% lower than its last 4 quarters average of 14.4 and 41% lower than its 5-year quarterly average of 9.2
NTRA's revenue is up by 49% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is Natera business performance
The ROA has dropped by 64% year-on-year and by 9% since the previous quarter
The return on invested capital has dropped by 63% year-on-year and by 14% since the previous quarter
The ROE has plunged by 60% YoY and by 7% from the previous quarter
The ROS has decreased by 49% YoY and by 9% from the previous quarter

Dividends

What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRA.

Financial health

How did Natera financials performed over time
NTRA's total assets is 90% higher than its total liabilities
NTRA's total assets is up by 28% YoY but it is down by 7% QoQ
The quick ratio has declined by 16% since the previous quarter and by 10% year-on-year
The company's debt is 27% lower than its equity
NTRA's equity is up by 46% year-on-year but it is down by 17% since the previous quarter
The debt to equity has contracted by 28% YoY but it has grown by 22% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.